Fair Value (Tables)

12 Months Ended

Dec. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

Financial instruments measured at fair value on a recurring basis and their location within the accompanying consolidated financial statements are as follows:

	December 31, 2019
(in thousands)	Level 1		Level 2		Level 3		Total		Location on Balance Sheet
Assets:
Forward contract agreements	$	—	$	733	$	—	$	733	Prepaid expenses and other
Deferred compensation investments in cash surrender life insurance		—		15,020		—		15,020	Other assets
Total	$	—	$	15,753	$	—	$	15,753
Liabilities:
Deferred compensation plan liabilities	$	—	$	14,855	$	—	$	14,855	Long-term Liabilities: Other
Interest rate swaps		—		3,811		—		3,811	Long-term Liabilities: Other
Total	$	—	$	18,666	$	—	$	18,666

	December 31, 2018
(in thousands)	Level 1		Level 2		Level 3		Total		Location on Balance Sheet
Assets:
Deferred compensation investments in cash surrender life insurance	$	—	$	12,816	$	—	$	12,816	Other assets
Liabilities:
Deferred compensation plan liabilities	$	—	$	12,703	$	—	$	12,703	Long-term Liabilities: Other
Interest rate swaps		—		782		—		782	Long-term Liabilities: Other
Contingent liability related to acquisition		—		—		1,750		1,750	Accrued expenses and other current liabilities
Total	$	—	$	13,485	$	1,750	$	15,235